The American Journal of Managed Care® Examines How Chronic Hepatitis C and Its Treatment Affect Medicaid Costs

Industry experts discuss the hepatitis C virus and how it affects healthcare costs in Medicaid

CRANBURY, N.J.--()--A recent supplement from The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, included a study on the hepatitis C virus (HCV) and the impact of antiviral use on healthcare costs.

In the supplement, industry experts assess the burden of chronic HCV infection and estimate the impact of interferon-free direct-acting antiviral treatment on healthcare costs in Medicaid.

The study was carried out by M. Christopher Roebuck, PhD, chief executive officer of RxEconomics LLC, and Joshua N. Liberman, PhD, chief operating officer of Health Analytics LLC. According to the results of the study: “Annual per-person Medicaid healthcare costs attributed to HCV infection were estimated to range from $10,561 for noncirrhotic disabled adults to $46,263 for nondisabled adults with end-stage liver disease. The costs were due mainly to inpatient hospitalizations and outpatient hospital visits, prescription drug utilization, outpatient physician’s office/clinic visits, and laboratory tests.”

This observational study explores claims from Medicaid that estimate the annual and cumulative effect of these curative medications on national Medicaid costs from 2013 through 2022.

About The American Journal of Managed Care®

The American Journal of Managed Care® (AJMC®) is a multimedia peer-reviewed, Medline-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision-makers as they work to promote the efficient delivery of high-quality care. AJMC.com is the essential website for managed care professionals, distributing industry updates daily to leading stakeholders. Other titles in the AJMC® family include The American Journal of Accountable Care® and two evidence-based series, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive offerings bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. To order reprints of articles appearing in AJMC® publications, please contact Gil Hernandez at 609-716-7777, ext. 139.

Contacts

AJMC® Media
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com

John Patricolo, 609-325-4630
jpatricolo@mjhassoc.com

Release Summary

The American Journal of Managed Care® Examines How Chronic Hepatitis C and Its Treatment Affect Medicaid Costs

Contacts

AJMC® Media
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com

John Patricolo, 609-325-4630
jpatricolo@mjhassoc.com